3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
14
Myeloid
2
Lymphoid
2
Plasma cell
1
Classical hematology
1
Conditions
Multiple Myeloma
20
Lymphoma
5
Neoplasms, Plasma Cell
4
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Hodgkin Disease
2
Smoldering Multiple Myeloma
1
Sarcoma
1
Paraproteinemias
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Monoclonal Gammopathy of Undetermined Significance
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Immunoglobulin Light-chain Amyloidosis
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Disease
1
Carcinoma
1
Amyloidosis
1
Alzheimer Disease
1
Interventions
fludarabine phosphate
19
fludarabine
18
Cyclophosphamide
16
Tacrolimus
12
Whole-Body Irradiation
11
Melphalan
11
Mycophenolic Acid
10
Bortezomib
9
Busulfan
8
trametinib
7
Dexamethasone
7
thymoglobulin
6
Stem Cell Transplantation
6
Lenalidomide
6
Cyclosporine
6
Sirolimus
5
Nivolumab
5
Methotrexate
5
dabrafenib
4
Rituximab
4
Peripheral Blood Stem Cell Transplantation
4
Granulocyte Colony-Stimulating Factor
4
Antilymphocyte Serum
4
Alemtuzumab
4
daratumumab
3
aldesleukin
3
Thiotepa
3
Specimen Handling
3
Ipilimumab
3
Interleukin-2
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
Blood Specimen Collection
×
Plasma cell
×
Clear all
NCT05735704
2025-03-26
SANGUINE
JaxBio Ltd
Unknown
3,000 enrolled